TOT BIOPHARM International Co Ltd
HKEX:1875
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TOT BIOPHARM International Co Ltd
HKEX:1875
|
CN |
|
Transat AT Inc
TSX:TRZ
|
CA |
|
B
|
Biokarpet Industrial and Commercial Enterprises SA
ATHEX:BIOKA
|
GR |
|
Repsol SA
MAD:REP
|
ES |
|
International Personal Finance PLC
LSE:IPF
|
UK |
|
SAI Leisure Group Co Ltd
HKEX:1832
|
HK |
|
Y
|
YeaRimDang Publishing Co Ltd
KOSDAQ:036000
|
KR |
|
Angus Gold Inc
XTSX:GUS
|
CA |
|
Bialetti Industrie SpA
MIL:BIA
|
IT |
|
Z
|
Zhejiang HangKe Technology Incorporated Co
SSE:688006
|
CN |
|
Silver Viper Minerals Corp
XTSX:VIPR
|
CA |
|
Huangshan Tourism Development Co Ltd
SSE:600054
|
CN |
|
A
|
Anzheng Fashion Group Co Ltd
SSE:603839
|
CN |
|
Yijiahe Technology Co Ltd
SSE:603666
|
CN |
Bankruptcy Probability
TOT BIOPHARM International Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
TOT BIOPHARM International Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
T
|
TOT BIOPHARM International Co Ltd
HKEX:1875
|
3.8B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
TOT BIOPHARM International Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, TOT BIOPHARM International Co Ltd has total debt of 355.8m CNY. This includes both short-term (0 CNY) and long-term (355.8m CNY) debt.
You can find a full breakdown on its Balance Sheet.
